Pursuant to a resolution passed by shareholders on June 16, 2014, the company has consolidated its capital on a 1:10 new basis. The name of the company has not been changed.
Effective at the opening on Monday, March 2, 2015, the common shares of Angel Bioventures Inc. will commence trading on the TSX Venture Exchange on a consolidated basis. The company is temporarily unclassified and is an NEX issuer.
Postconsolidation
Capitalization: unlimited shares with no par value of which
1,188,852 shares are issued and outstanding
Escrow: nil
Transfer agent: TMX Equity Transfer Services
Trading symbol: DDD.H (unchanged)
Cusip No.: 03463H205 (new)
© 2024 Canjex Publishing Ltd. All rights reserved.